Global Venous Thromboembolism Therapeutic Market by Drug Class (Direct Thrombin Inhibitors, Factor XA Inhibitors, Heparin), Device (Compression System, IVC Filters, Stockings), Application, End-use - Forecast 2024-2030- Product Image

Sale

Global Venous Thromboembolism Therapeutic Market by Drug Class (Direct Thrombin Inhibitors, Factor XA Inhibitors, Heparin), Device (Compression System, IVC Filters, Stockings), Application, End-use - Forecast 2024-2030

Report
195 Pages
March 2024
Region: Global
360iResearch™
ID: 4986090

UP TO €846EUR$875USD£727GBP OFF until Dec 31^st 2024

The Venous Thromboembolism Therapeutic Market size was estimated at USD 2.40 billion in 2023, USD 2.54 billion in 2024, and is expected to grow at a CAGR of 5.84% to reach USD 3.57 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Venous Thromboembolism Therapeutic Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Venous Thromboembolism Therapeutic Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Venous Thromboembolism Therapeutic Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AngioDynamics, Inc., Argon Medical Devices, Inc., Arjo AB, Bio Compression Systems, BioInvent International AB, Boehringer Ingelheim International GmbH, Boston Scientific Corporation, Bristol-Myers Squibb Company, Cardinal Health, Inc., Cook Group Incorporated, DAIICHI SANKYO COMPANY, LIMITED, eXIthera Pharmaceuticals, Koninklijke Philips N.V., Medtronic PLC, and Sanofi S.A.

Market Segmentation & Coverage

This research report categorizes the Venous Thromboembolism Therapeutic Market to forecast the revenues and analyze trends in each of the following sub-markets:

Drug Class
- Direct Thrombin Inhibitors
- Factor XA Inhibitors
- Heparin
- Vitamin K Antagonists
Device
- Compression System
- IVC Filters
- Stockings
- Thrombectomy Systems
Application
- Deep vein Thrombosis
- Pulmonary Embolism
End-use
- Catheterization Laboratories
- Hospitals

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Venous Thromboembolism Therapeutic Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Venous Thromboembolism Therapeutic Market?
What are the technology trends and regulatory frameworks in the Venous Thromboembolism Therapeutic Market?
What is the market share of the leading vendors in the Venous Thromboembolism Therapeutic Market?
Which modes and strategic moves are suitable for entering the Venous Thromboembolism Therapeutic Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Venous Thromboembolism Therapeutic Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Escalating rate of venous thromboembolism
5.1.1.2. Increasing surgical procedures such as hip and knee replacements
5.1.1.3. Increase in patient awareness towards VTE treatment
5.1.2. Restraints
5.1.2.1. High treatment cost and side effects associated with VTE drugs
5.1.3. Opportunities
5.1.3.1. Development of efficient and advanced technology
5.1.3.2. Government initiatives for venous thromboembolism treatments
5.1.4. Challenges
5.1.4.1. Stringent and complex regulatory procedures
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Venous Thromboembolism Therapeutic Market, by Drug Class

6.1. Introduction
6.2. Direct Thrombin Inhibitors
6.3. Factor XA Inhibitors
6.4. Heparin
6.5. Vitamin K Antagonists

7. Venous Thromboembolism Therapeutic Market, by Device

7.1. Introduction
7.2. Compression System
7.3. IVC Filters
7.4. Stockings
7.5. Thrombectomy Systems

8. Venous Thromboembolism Therapeutic Market, by Application

8.1. Introduction
8.2. Deep vein Thrombosis
8.3. Pulmonary Embolism

9. Venous Thromboembolism Therapeutic Market, by End-use

9.1. Introduction
9.2. Catheterization Laboratories
9.3. Hospitals

10. Americas Venous Thromboembolism Therapeutic Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Venous Thromboembolism Therapeutic Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Venous Thromboembolism Therapeutic Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

14.1. Key Company Profiles
14.1.1. Abbott Laboratories
14.1.2. AngioDynamics, Inc.
14.1.3. Argon Medical Devices, Inc.
14.1.4. Arjo AB
14.1.5. Bio Compression Systems
14.1.6. BioInvent International AB
14.1.7. Boehringer Ingelheim International GmbH
14.1.8. Boston Scientific Corporation
14.1.9. Bristol-Myers Squibb Company
14.1.10. Cardinal Health, Inc.
14.1.11. Cook Group Incorporated
14.1.12. DAIICHI SANKYO COMPANY, LIMITED
14.1.13. eXIthera Pharmaceuticals
14.1.14. Koninklijke Philips N.V.
14.1.15. Medtronic PLC
14.1.16. Sanofi S.A.
14.2. Key Product Portfolio

15. Appendix

15.1. Discussion Guide
15.2. License & Pricing

List of Figures

FIGURE 1. VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET RESEARCH PROCESS
FIGURE 2. VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, 2023 VS 2030
FIGURE 3. VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET DYNAMICS
FIGURE 7. VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2023 VS 2030 (%)
FIGURE 8. VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DEVICE, 2023 VS 2030 (%)
FIGURE 10. VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DEVICE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 14. VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 6. VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DIRECT THROMBIN INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY FACTOR XA INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY HEPARIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY VITAMIN K ANTAGONISTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 11. VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY COMPRESSION SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY IVC FILTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY STOCKINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY THROMBECTOMY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 16. VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY PULMONARY EMBOLISM, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 19. VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY CATHETERIZATION LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 33. BRAZIL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 34. CANADA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 35. CANADA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 36. CANADA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. CANADA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 38. MEXICO VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 39. MEXICO VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 40. MEXICO VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 41. MEXICO VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 52. AUSTRALIA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 53. AUSTRALIA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 54. AUSTRALIA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. AUSTRALIA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 56. CHINA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 57. CHINA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 58. CHINA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. CHINA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 60. INDIA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 61. INDIA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 62. INDIA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. INDIA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 64. INDONESIA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 65. INDONESIA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 66. INDONESIA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. INDONESIA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 68. JAPAN VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 69. JAPAN VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 70. JAPAN VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. JAPAN VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 72. MALAYSIA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 73. MALAYSIA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 74. MALAYSIA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. MALAYSIA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 76. PHILIPPINES VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 77. PHILIPPINES VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 78. PHILIPPINES VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. PHILIPPINES VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 80. SINGAPORE VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 81. SINGAPORE VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 82. SINGAPORE VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. SINGAPORE VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 84. SOUTH KOREA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 85. SOUTH KOREA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 86. SOUTH KOREA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. SOUTH KOREA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 88. TAIWAN VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 89. TAIWAN VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 90. TAIWAN VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. TAIWAN VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 92. THAILAND VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 93. THAILAND VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 94. THAILAND VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. THAILAND VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 96. VIETNAM VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 97. VIETNAM VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 98. VIETNAM VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. VIETNAM VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 105. DENMARK VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 106. DENMARK VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 107. DENMARK VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. DENMARK VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 109. EGYPT VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 110. EGYPT VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 111. EGYPT VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. EGYPT VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 113. FINLAND VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 114. FINLAND VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 115. FINLAND VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. FINLAND VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 117. FRANCE VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 118. FRANCE VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 119. FRANCE VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. FRANCE VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 121. GERMANY VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 122. GERMANY VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 123. GERMANY VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. GERMANY VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 125. ISRAEL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 126. ISRAEL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 127. ISRAEL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. ISRAEL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 129. ITALY VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 130. ITALY VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 131. ITALY VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. ITALY VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. NIGERIA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 141. NORWAY VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 142. NORWAY VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 143. NORWAY VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. NORWAY VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 145. POLAND VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 146. POLAND VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 147. POLAND VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. POLAND VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 149. QATAR VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 150. QATAR VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 151. QATAR VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. QATAR VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 165. SPAIN VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 166. SPAIN VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 167. SPAIN VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. SPAIN VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 169. SWEDEN VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 170. SWEDEN VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 171. SWEDEN VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. SWEDEN VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 173. SWITZERLAND VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 174. SWITZERLAND VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 175. SWITZERLAND VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. SWITZERLAND VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 177. TURKEY VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 178. TURKEY VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 179. TURKEY VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. TURKEY VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 189. VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 190. VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SHARE, BY KEY PLAYER, 2023
TABLE 191. VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET LICENSE & PRICING

Companies Mentioned

Abbott Laboratories
AngioDynamics, Inc.
Argon Medical Devices, Inc.
Arjo AB
Bio Compression Systems
BioInvent International AB
Boehringer Ingelheim International GmbH
Boston Scientific Corporation
Bristol-Myers Squibb Company
Cardinal Health, Inc.
Cook Group Incorporated
DAIICHI SANKYO COMPANY, LIMITED
eXIthera Pharmaceuticals
Koninklijke Philips N.V.
Medtronic PLC
Sanofi S.A.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	195
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 2.54 Billion
Forecasted Market Value ( USD ) by 2030	$ 3.57 Billion
Compound Annual Growth Rate	5.8%
Regions Covered	Global
No. of Companies Mentioned	16

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3262EUR$3,374USD£2,802GBP €3624EUR$3,749USD£3,113GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4132EUR$4,274USD£3,549GBP €4591EUR$4,749USD£3,944GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5002EUR$5,174USD£4,297GBP €5558EUR$5,749USD£4,774GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5872EUR$6,074USD£5,044GBP €6525EUR$6,749USD£5,605GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7613EUR$7,874USD£6,539GBP €8458EUR$8,749USD£7,265GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Venous Thromboembolism Therapeutics Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

Global Venous Thromboembolism Treatment Market by Device (Thrombectomy, Inferior Vena Cava Filter [Retrievable, Permanent], Stockings, Compression Pump) Application (DVT, Pulmonary Embolism) End User (Hospital, Ambulatory Care Center) - Forecast to 2030

Global Venous Thromboembolism Therapeutic Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

Venous Thromboembolism Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2032

Venous Thromboembolism (VTE) Epidemiology Analysis and Forecast to 2032